Promethera: Promethera Biosciences : Presents Updated Clinical Results at AASLD 2019 for World's First Stem Cell Therapy Trial using HepaStem in Acute-on-Chronic Liver Failure

(marketscreener.com) 3-Month Follow-up Data from the Fully Recruited Phase 2a Trial with a Total of 24 Patients Confirms Safety and Early Efficacy Trends and Dosing Regimen for Subsequent...http://www.marketscreener.com/news/Promethera-Biosciences-Presents-Updated-Clinical-Results-at-AASLD-2019-for-World-s-First-Stem-Cell--29558928/?utm_medium=RSS&utm_content=20191111